Generali has partnered with MIT’s Laboratory for Information and Decision Systems (LIDS) to leverage Artificial Intelligence (AI) in the insurance sector, starting in January 2025.…
NeuroBionics, an MIT spinout, aims to transform the treatment of neurological disorders like depression and Parkinson’s disease through innovative neuromodulation therapy. The startup is developing…